Validation and clinical application of computer-combined computed tomography and positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose head and neck images
References (14)
Carcinoma of the larynx: the role of imaging in staging and pre-treatment assessments
Clin Radiol
(1992)- et al.
Magnetic Resonance imaging vs palpation of cervical lymph node metastases
Arch Otoloaryngol
(1991) - et al.
Radiologic diagnosis and staging of head and neck squamous cell carcinoma
Radiol Clin North Am-Staging Neoplasms
(1994) On the origin of cancer cells
Science
(1956)- et al.
The application of PET in clinical oncology
J Nucl Med
(1991) - et al.
Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumours and assessment of cervical adenopathy
Laryngoscope
(1992) - et al.
Glucose uptake, perfusion, and cell proliferation in head and neck tumours: relation of positron emission tomography to flow cytometry
J Nucl Med
(1991)
Cited by (69)
PET-CT for Staging and Detection of Recurrence of Head and Neck Cancer
2021, Seminars in Nuclear MedicineCitation Excerpt :The value of positron emission tomography (PET) for head and neck (H&N) cancer was recognised very early in the history of PET. H&N cancer was identified as one of the first clinical indications for PET.1,2 The advent PET-CT saw an acceleration of the clinical utility of this technique.
The role of FDG PET in the diagnosis of occult primary with cervical lymph node metastases: A meta-analysis study
2014, Egyptian Journal of Ear, Nose, Throat and Allied SciencesTarget volume delineation in oropharyngeal cancer: Impact of PET, MRI, and physical examination
2012, International Journal of Radiation Oncology Biology Physics18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Assessment of Occult Primary Head and Neck Cancers - An Audit and Review of Published Studies
2012, Clinical OncologyCitation Excerpt :However, FDG PET provides limited anatomical information and localisation of small foci of tracer uptake is a challenge even with morphological imaging side by side with PET. Image fusion algorithms, which combine FDG PET to computed tomography (CT) or magnetic resonance (MR), have been successfully developed in the head and neck, but their implementation into a clinical setting is difficult because application of these techniques is both labour intensive and time consuming [14]. Another important limitation of image fusion is that some misregistration is almost inevitable, even if the patient’s head and neck is in identical positions for the two separate scans.
Segmentation of positron emission tomography images: Some recommendations for target delineation in radiation oncology
2010, Radiotherapy and OncologyCitation Excerpt :More importantly, the ground truth behind these images is nearly out of reach. In order to measure the tumour volume and its contours, the physician needs to acquire images with another modality than PET (e.g., CT) and/or to surgically extract the tumour [12,23,67,68]. Both ways are paved with difficulties.
Metabolic markers of the head and neck cancers - Clinical applications and the biochemical background
2009, Otolaryngologia Polska